News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
296,366 Results
Type
Article (15101)
Company Profile (36)
Press Release (281229)
Multimedia
Podcasts (23)
Webinars (5)
Section
Business (80634)
Career Advice (1337)
Deals (16001)
Drug Delivery (34)
Drug Development (48493)
Employer Resources (54)
FDA (7769)
Job Trends (6502)
News (151429)
Policy (12633)
Tag
Academia (1008)
Accelerated approval (4)
Adcomms (12)
Allergies (67)
Alliances (15298)
ALS (61)
Alzheimer's disease (729)
Antibody-drug conjugate (ADC) (117)
Approvals (7839)
Artificial intelligence (171)
Autoimmune disease (23)
Automation (10)
Bankruptcy (118)
Best Places to Work (5669)
BIOSECURE Act (4)
Biosimilars (67)
Biotechnology (27)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (301)
Cancer (2085)
Cardiovascular disease (137)
Career advice (1039)
Career pathing (11)
CAR-T (98)
CDC (9)
Cell therapy (279)
Cervical cancer (18)
Clinical research (42563)
Collaboration (581)
Company closure (1)
Compensation (420)
Complete response letters (10)
COVID-19 (1238)
CRISPR (33)
C-suite (132)
Cystic fibrosis (50)
Data (2207)
Denatured (1)
Depression (30)
Diabetes (206)
Diagnostics (2738)
Digital health (15)
Diversity, equity & inclusion (11)
Drug discovery (72)
Drug pricing (29)
Drug shortages (10)
Duchenne muscular dystrophy (82)
Earnings (51233)
Editorial (16)
Employer branding (8)
Employer resources (47)
Events (48237)
Executive appointments (466)
FDA (8870)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (532)
Gene editing (71)
Generative AI (9)
Gene therapy (223)
GLP-1 (466)
Government (1670)
Grass and pollen (5)
Guidances (167)
Healthcare (8176)
Huntington's disease (19)
IgA nephropathy (27)
Immunology and inflammation (87)
Immuno-oncology (5)
Indications (30)
Infectious disease (1336)
Inflammatory bowel disease (82)
Inflation Reduction Act (6)
Influenza (42)
Intellectual property (66)
Interviews (250)
IPO (9706)
IRA (12)
Job creations (1187)
Job search strategy (910)
Kidney cancer (12)
Labor market (26)
Layoffs (213)
Leadership (12)
Legal (2049)
Liver cancer (56)
Lung cancer (300)
Lymphoma (167)
Machine learning (7)
Management (17)
Manufacturing (167)
MASH (73)
Medical device (5915)
Medtech (5915)
Mergers & acquisitions (6790)
Metabolic disorders (502)
Multiple sclerosis (73)
NASH (17)
Neurodegenerative disease (72)
Neuropsychiatric disorders (17)
Neuroscience (1153)
NextGen: Class of 2025 (2420)
Non-profit (2094)
Now hiring (8)
Obesity (234)
Opinion (98)
Ovarian cancer (70)
Pain (68)
Pancreatic cancer (89)
Parkinson's disease (120)
Partnered (4)
Patents (147)
Patient recruitment (89)
Peanut (35)
People (13594)
Pharmaceutical (14)
Pharmacy benefit managers (6)
Phase I (10625)
Phase II (17495)
Phase III (18084)
Pipeline (1340)
Policy (55)
Postmarket research (1374)
Preclinical (3609)
Press Release (18)
Prostate cancer (107)
Psychedelics (13)
Radiopharmaceuticals (131)
Rare diseases (269)
Real estate (1539)
Recruiting (21)
Regulatory (10258)
Reports (30)
Research institute (924)
Resumes & cover letters (256)
Rett syndrome (7)
RNA editing (3)
RSV (34)
Schizophrenia (65)
Series A (81)
Series B (56)
Service/supplier (5)
Sickle cell disease (38)
Special edition (18)
Spinal muscular atrophy (106)
Sponsored (16)
Startups (1083)
Stomach cancer (6)
Supply chain (46)
Tariffs (21)
The Weekly (22)
Vaccines (410)
Venture capital (27)
Weight loss (125)
Women's health (21)
Worklife (10)
Date
Today (86)
Last 7 days (377)
Last 30 days (1807)
Last 365 days (21259)
2025 (10843)
2024 (20540)
2023 (21229)
2022 (25568)
2021 (26883)
2020 (25280)
2019 (20186)
2018 (15167)
2017 (15632)
2016 (13557)
2015 (16116)
2014 (11829)
2013 (8845)
2012 (9257)
2011 (9743)
2010 (8375)
Location
Africa (376)
Alabama (22)
Alaska (3)
Arizona (48)
Arkansas (8)
Asia (20892)
Australia (3895)
California (4928)
Canada (1307)
China (448)
Colorado (203)
Connecticut (225)
Delaware (146)
Europe (43135)
Florida (616)
Georgia (145)
Idaho (19)
Illinois (382)
India (16)
Indiana (200)
Iowa (9)
Japan (184)
Kansas (57)
Kentucky (9)
Louisiana (7)
Maine (38)
Maryland (521)
Massachusetts (3496)
Michigan (95)
Minnesota (254)
Mississippi (3)
Missouri (50)
Montana (12)
Nebraska (6)
Nevada (50)
New Hampshire (38)
New Jersey (1397)
New Mexico (8)
New York (1305)
North Carolina (627)
North Dakota (4)
Northern California (2212)
Ohio (129)
Oklahoma (3)
Oregon (15)
Pennsylvania (942)
Puerto Rico (9)
Rhode Island (15)
South America (545)
South Carolina (15)
Southern California (1844)
Tennessee (68)
Texas (698)
United States (17007)
Utah (115)
Virginia (117)
Washington D.C. (35)
Washington State (414)
West Virginia (2)
Wisconsin (58)
296,366 Results for "3".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
3DBioFibR Raises $3M to Advance Next-Gen Biopolymer Fiber Manufacturing Platform
June 4, 2025
·
3 min read
Press Releases
Penicillin Drug Market to Reach USD 13.93 Billion by 2032, Growing at a CAGR of 3.3% | Coherent Market Insights
June 16, 2025
·
1 min read
Press Releases
HER3-DXd shows promising results in the phase II TUXEDO-3 study for patients with limited therapeutic options
June 2, 2025
·
6 min read
Press Releases
Apellis and Sobi Announce EMPAVELI® (pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN
June 9, 2025
·
7 min read
Press Releases
Adial Pharmaceuticals Announces Pricing of $3.6 Million Public Offering
June 18, 2025
·
6 min read
Press Releases
Vistagen on Track to Deliver Topline Data From Fasedienol PALISADE-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year
June 2, 2025
·
8 min read
Press Releases
Biodexa Announces Award of Additional $3.0M Grant from CPRIT to Support Registrational eRapa Phase 3 Program in FAP Brings Total CPRIT Grant Funding for eRapa Phase 3 Program to $20.0M
May 22, 2025
·
7 min read
Press Releases
Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04
June 11, 2025
·
6 min read
Press Releases
Bavarian Nordic Initiates Phase 3 Study of Chikungunya Vaccine in Children
June 12, 2025
·
5 min read
Press Releases
Merck Initiates Phase 3 Study Evaluating Dengue Vaccine Candidate
June 12, 2025
·
6 min read
1 of 29,637
Next
